Quiksilver warns of tough ride
Eli Greenblat THE leading surf, skate and snowboard apparel brand Quiksilver has joined rival Billabong to warn of tough trading conditions for branded clothes, especially among youth-aligned retailers, with...
Biotech IPO to target key ailments as Australia ages
Eli Greenblat Broadvector has locked its gaze on two ailments which are tipped to boom along with the greying of the population - prostate cancer and hip replacements.
Cash register rings at Grace Bros family's final sale
Eli Greenblat ONE of the last remaining relics of the once mighty Grace Bros department store empire, a blue-chip equities portfolio valued at just over $40 million, has been sold by the family that once owned and...
Texans narrow focus to Sigma capital raising
PHARMACEUTICALS Eli Greenblat SIGMA PHARMACEUTICALS is expecting to be hit with a shareholder class action over its alleged failure to disclose its financial position before a capital raising last September.
Sigma faces class action over disclosure
Eli Greenblat Sigma Pharmaceuticals expects to be hit with a shareholder class action lawsuit over its alleged failure to disclose its financial position before a capital raising in September 2009.
Sales of Jacob's Creek drop in flooded market
Eli Greenblat THE French beverages giant Pernod Ricard has reported a 5 per cent drop in sales for its Australian wine Jacob's Creek and said the gradual economic recovery in the US and austerity measures in...
Hard to swallow
Eli Greenblat THE former Foster's Group chief executive, Trevor O'Hoy, has broken his silence over the future of the beverages giant he once led, saying a demerger of its wine and beer businesses makes perfect...
O'Hoy joins ASG board
Eli Greenblat IT services provider ASG Group announced this morning it had appointed former Foster's Group boss Trevor O'Hoy as a non-executive director on the ASG Board.
Pharmaxis in deal to support launch of cystic fibrosis drug
Eli Greenblat Biotech company Pharmaxis has finalised a strategic marketing and sales service agreement for the commercialisation of its cystic fibrosis drug, Bronchitol, for use in Europe.
Myer boss on defensive after setting cat among pigeons
Eli Greenblat THE chief executive of Myer, Bernie Brookes, was in damage control yesterday after a speech given in Perth suggested that he preferred running a private company to a public one and said communicating...
Upbeat Harvey Norman to resume opening stores
Eli Greenblat THE bedding and whitegoods retailer Harvey Norman will resume opening stores in country regions as well as adding one to its portfolio in Slovenia, as the Australian economy is buttressed by full...
'Like herding cats' - Myer chief's private yearnings
Eli Greenblat Myer chief executive Bernie Brookes says public listing takes up management time that could better be spent in stores.
Ramsay to go hospital shopping in France
Eli Greenblat RAMSAY HEALTH CARE has up to $600 million to spend on expanding its portfolio of hospitals in France as it fuses together a global hospitals business anchored by its large network in Australia and...
Woolworths toasts takings of $1b a week
Eli Greenblat WOOLWORTHS has powered through the global financial crisis to rack up its 11th consecutive year of profit growth, underscoring its balance sheet strength by treating investors to a $700 million share...
Sonic lowers guidance and looks overseas
Eli Greenblat A DELAYED rebound in the Australian pathology market following deep government funding cuts has forced Sonic Healthcare to lower the bottom end of its earnings guidance for 2011 and look increasingly...
Wine glut, flat beer leave Foster's in the doldrums
Eli Greenblat FOSTER'S has unveiled its first full-year loss since it emerged from the chaotic ashes of Elders IXL nearly two decades ago, and its once mighty brewing arm is feeling the pressure of competition...
Constellation to delist in Australia
Eli Greenblat US-based Constellation Brands, which owns Australia's largest wine business, Hardy Wine Co, has sought removal of its depository receipts from the ASX by November 17.
A bottler of a battle is brewing
Eli Greenblat Foster's has just become $850 million more expensive for international brewer SABMiller, which London's Sunday Times has reported is considering a takeover bid.
Foster's shares spike as speculation mounts over an international suitor
Eli Greenblat FOSTER'S has just become $850 million more expensive for the international brewer SABMiller - or anyone else interested - if London's Sunday Times is correct in reporting that the British beer...
Potash turns to others to see off BHP
Eli Greenblat and Barry FitzGerald BHP Billiton’s $US40 billion ($45 billion) bid for Canada’s Potash Corp has come under fresh attack from the target and faces the prospect of being gazumped by Chinese interests.
